| Cat. No. |
Product Name |
Information |
| PC-49099 |
5J89LIG
|
5J89LIG is a small molecule h-PD1/h-PD-L1 interaction inhibitor with IC50 of 18.0 nM, bind specifically to hPD-L1 through a unique mode of action, induces the dimerization of hPD-L1. |
| PC-49097 |
BMS135
|
BMS135 is a small molecule h-PD1/h-PD-L1 interaction inhibitor with IC50 of 79.1 nM, bind specifically to hPD-L1 through a unique mode of action, induces the dimerization of hPD-L1. |
| PC-38391 |
Evixapodlin
|
Evixapodlin (GS-4224) is a highly potent, small molecule human PD-1/PD-L1 protein-protein interaction inhibitor with IC50 of 0.213 nM, exhibits potential anticancer and antiviral activities. |
| PC-73047 |
PD-L1 inhibitor 4
|
PD-L1 inhibitor 4 is a small molecule inhibitor of PD-1/PD-L1 with SPR KD of 0.079 nM. |
| PC-72848 |
INCB086550
|
INCB086550 (INCB 086550) is a potent, selective small-molecule inhibitor of PD-L1, inhibits PD-L1/PD-1 interaction with IC50 of 3.1, 4.9 and 1.9 nM for human, cynomolgus and rat PD-L1 in HTRF-based assays. |
| PC-72764 |
ZE132
|
ZE132 is a potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with IC50 of <0.1 nM. |
| PC-72654 |
CA-170
|
CA-170 (CA170) is a first-in-class, orally available, tripeptide small-molecule dual antagonist of VISTA/PD-L1, important negative checkpoint regulators of immune activation. |
